HOBART A. REIMANN, M.D.
To the editor: The authors of a paper concerning colchicine for familial Mediterranean fever (FMF) (Ann Intern Med 81:792, 1974) omit mention of other views about terminology and nature of the disorder. One of their criteria for diagnosing familial Mediterranean fever is the "absence of amyloidosis." Yet in Sonar's cited paper "amyloidosis is the second major feature of FMF." As the main difference from periodic peritonitis (PP), familial Mediterranean fever involves a sect of Levantine and North African Jews. Amyloidosis occurred in 26% and was said to be fatal before the age of 40 years. Other observations on the same
REIMANN HA. Nomenclature: Familial Mediterranean Fever and Periodic Peritonitis. Ann Intern Med. ;82:433. doi: 10.7326/0003-4819-82-3-433_1
Download citation file:
Published: Ann Intern Med. 1975;82(3):433.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use